Last Updated: 06-07-2022 8:10
In order to come up with a suggested list of biomarkers, matrices and analytical methods for the 2nd prioritisation round of substances, partners in task 9.1 in collaboration with the chemical group leaders (CGLs) made inventories of available analytical methods as well as suitable exposure biomarkers and matrices. Information in the inventories was further evaluated by partners in task 9.1 following guidelines that had been thoroughly discussed and agreed upon. The CGLs and experts in WP9 and WP16 were consulted and gave their input to the draft of the deliverable. The substances have been categorised according to the scoping documents. The inventories and evaluations are revised and updated both in the year 2020 and 2021. Further, the progress made with respect to quality and harmonization/comparability of methods as a result of the HBM4EU QA/QC-program in task 9.4 is also elaborated.